What is Larifan?
An original active substance – Larifan was developed at the Latvian Academy of Sciences and at present is produced at Larifans Ltd. Larifan is a double-stranded RNA (dsRNA) of natural origin obtained from bacteriophage-infected E.coli cells. Larifan has been developed as a new poly-functional and wide-spectrum medical drug for viral and oncologic diseases.
Larifan possesses multiple biological activities like interferon-inducing, immunomodulating, antiviral, antitumoral and antimutagenic properties.
Drug and cosmetic forms and consumer goods of Larifan are registered in different European and Asian coutries